Bausch + Lomb BLCO Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Pharmaceuticals | $266M-16.6% | $319M+13.9% | $280M+7.7% | $260M+17.1% | $222M-17.2% | |
| Surgical | $228M-8.4% | $249M+15.8% | $215M-0.5% | $216M+0.9% | $214M-7.4% | |
| Vision Care | $711M-8.6% | $778M+5.7% | $736M-2.3% | $753M+14.8% | $656M-9.3% | |
| Total revenues by Product | ||||||
| Branded and Other Generics | $49M-31.0% | $71M+20.3% | $59M+1.7% | $58M+7.4% | $54M-21.7% | |
| Devices | $480M-7.3% | $518M+7.0% | $484M+2.5% | $472M+5.4% | $448M-5.9% | |
| OTC | $444M-9.4% | $490M+7.9% | $454M-5.8% | $482M+17.8% | $409M-11.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch + Lomb break its business down?
- Bausch + Lomb (BLCO) reports total revenues by business across 3 parts — Pharmaceuticals, Surgical and Vision Care. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch + Lomb's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch + Lomb's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.